US Patent 9321841 Humanised anti-CD52 antibodies
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
The present invention relates to novel humanised antibodies against human CD52 and their use in methods of treating or preventing human diseases.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09321841 Humanised anti-CD52 antibodies US Patent 9321841 Humanised anti-CD52 antibodies
Infobox
Patent Number
0932184100
Patent Number
932184100
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
093218410
Date of Patent
April 26, 2016
0Patent Application Number
141233490
Date Filed
June 1, 2012
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
093218410
Date of Patent
April 26, 2016
0Patent Application Number
141233490
Date Filed
June 1, 2012
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09321841 Humanised anti-CD52 antibodies
Infobox
Is a
Patent jurisdiction
Patent number
09321841
Date of patent
April 26, 2016
Patent application number
14123349
Date Filed
June 1, 2012
Patent primary examiner
Find more entities like US Patent 9321841 Humanised anti-CD52 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
